Eric Walker added Bedaquiline-linezolid-pretomanid (BPaL) and 2020-07 Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid: A Prospective Multi-country Study and Bedaquiline - Wikipedia and FDA approves Sirturo for treating children with pulmonary multidrug-resistant TB - Outbreak News Today to Bedaquiline, and added Bedaquiline to Janssen Pharmaceuticals and Proton-pump inhibitors
Eric Walker added a number of links to Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid: A Prospective Multi-country Study, and added Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid: A Prospective Multi-country Study to Multidrug-resistant tuberculosis (MDR-TB), Bedaquiline and Delamanid
Eric Walker added 2020-07 Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid: A Prospective Multi-country Study and a number of links to Delamanid, and added Delamanid to Nitroimidazoles and Otsuka Pharmaceutical
Eric Walker added Extensively drug-resistant tuberculosis (XDR-TB), 2019-07 London School of Hygiene & Tropical Medicine study on MDR-TB and 2020-07 Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid: A Prospective Multi-country Study and a number of links to Multidrug-resistant tuberculosis (MDR-TB), and added Multidrug-resistant tuberculosis (MDR-TB) to Drug-resistant tuberculosis (DR-TB)